latest news releases from the newsroom
Bookham Technology Plc
Bookham Technology Plc -- 3rd Quarter Results
OXFORDSHIRE, U.K., Oct. 28, 2003 (PRIMEZONE) -- Bookham Technology plc (LSE:BHM) (Nasdaq:BKHM), a leading provider of optical components, modules and subsystems for fiber optic communication networks, today announced results for the third quarter ended September 28, 2003.
Trintech Group Plc
Trintech Achieves Visa PED Certification on Bank-Accredited PIN Pad Terminals
LONDON and DALLAS Oct. 28, 2003 (PRIMEZONE) -- Trintech Group Plc (Nasdaq:TTPA) (Prime Standard:TTP), a leading provider of transaction management and payment infrastructure solutions, today announced that it has achieved Visa PED (PIN Entry Device) certification on its bank-accredited Smart 5000 and Compact 950 PINPad terminals. This certification follows Trintech's success in being the first company to receive acquirer approval for its integrated point-of-sale EMV Chip and PIN solution.
Urban Backstrom new CEO of Skandia Liv
STOCKHOLM, Sweden, Oct. 28, 2003 (PRIMEZONE) -- Former head of Riksbanken (the Swedish Central Bank) Urban Backstrom has been named President and CEO of Skandia Liv. He will take office on 1 November.
Investor positive toward ABB's new rights issue
STOCKHOLM, Sweden, Oct. 28, 2003 (PRIMEZONE) -- Investor's President and CEO Marcus Wallenberg made the following statement today in connection with ABB's announcement that it would carry out a rights issue of new shares:
Celltech Group plc
Celltech Achieves Milestone in Osteoporosis Collaboration with Amgen
SLOUGH, U.K., Oct. 28, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announced the achievement of a milestone in its agreement with Amgen Inc. for the research, development and global commercialisation of novel treatments for osteoporosis using Celltech's proprietary antibody fragment technology, which aims to identify antibody fragments against sclerostin, a protein discovered by Celltech. Sclerostin is involved in the regulation of bone deposition, and it is believed that by inhibiting this protein, bone loss in osteoporosis patients may be reversed. Amgen and Celltech scientists have identified a high-affinity function modifying Celltech antibody for further study, triggering an undisclosed milestone payment to Celltech.
Credit Suisse Group
Winterthur to restructure its sales organization in Switzerland
ZURICH, Switzerland, Oct. 28, 2003 (PRIMEZONE) -- Credit Suisse Group: Winterthur Group announced today that it will combine the two separate sales organizations of its life and non-life operations within the Market Unit Switzerland Non-Life. The reorganization will generate necessary cost savings and create a clearer management structure, enabling Winterthur to offer customers advice on pensions and insurance matters from a single source, in line with their requirements.
Atoms of God - New book of poetry addresses ideas, emotions encountered on the inward spiritual path
DURANGO, Colo., Oct. 27, 2003 (PRIMEZONE) -- When people determine their individual spiritual paths, they can either accept what people tell them or they can examine each piece and retain only what they feel in their hearts to be true. The choice is always theirs, writes author Alexandria Renee Omikami in her book of poetry, Atoms of God: Reclaiming Divinity (now available through 1stBooks). She takes readers through a series of poems that outline her own spiritual journey, allowing them to take what they need to encourage spiritual growth.